Heyman Richard A.

Director at RayzeBio, Inc. · on record since Sep 14, 2023
Director at KINETA, INC./DE · on record since Dec 28, 2020
Director at VivoSim Labs, INC. · on record since Aug 23, 2013
Director at Receptos, Inc. · on record since Jul 29, 2014
Director at Gritstone bio, Inc. · on record since Sep 27, 2018
Director at Oric Pharmaceuticals, Inc. · on record since Apr 28, 2020
Director at PMV Pharmaceuticals, Inc. · on record since Sep 24, 2020
Director at Metacrine, Inc. · on record since Sep 16, 2020
Director at Tango Therapeutics, Inc. · on record since Sep 3, 2020
Director at Enliven Therapeutics, Inc. · on record since Feb 27, 2023

Insider trading activity of Heyman Richard A.

Transactions on record: 123; since Aug 23, 2013

Open-market buys: 0

Open-market sells: 64; $1.8M

Companies traded: 9; last filing Oct 2, 2026

Figures computed from official regulatory filings — .

Companies where Heyman Richard A. has traded

Oric Pharmaceuticals, Inc.40 tx · $677.7K · Oct 2, 2026
Enliven Therapeutics, Inc.42 tx · $1.1M · Feb 19, 2026
PMV Pharmaceuticals, Inc.22 tx · $1.1M · Jun 9, 2025
RayzeBio, Inc.1 tx · $23M · Feb 27, 2024
Metacrine, Inc.2 tx · Sep 6, 2022
Gritstone bio, Inc.4 tx · Jun 22, 2022
4 tx · Jun 4, 2021
4 tx · $3.6M · Aug 27, 2015
4 tx · Aug 24, 2015

Track record of Heyman Richard A.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Heyman Richard A.

Co-insiders of Heyman Richard A.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Oric Pharmaceuticals, Inc.Listing on record	Oct 2, 2026	Exercise	3,500	1.60 USD	$5.6K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 2, 2026	ExerciseD (derivative)	-3,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 2, 2026	Sell	-3,200	12.91 USD	$41.3K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 2, 2026	Sell	-3,500	12.91 USD	$45.2K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jul 28, 2026	ExerciseD (derivative)	-3,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jul 28, 2026	Sell	-6,100	12.02 USD	$73.3K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jul 28, 2026	Sell	-7,000	12.02 USD	$84.1K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jul 28, 2026	Exercise	3,500	1.60 USD	$5.6K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jul 8, 2026	Sell	-300	12.00 USD	$3.6K		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 19, 2026	Sell	-1,230	26.18 USD	$32.2K		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 17, 2026	AwardD (derivative)	19,234	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Jan 22, 2026	Sell	-512	26.46 USD	$13.5K		SEC
Enliven Therapeutics, Inc.Listing on record	Jan 22, 2026	Sell	-718	26.96 USD	$19.4K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jan 20, 2026	Sell	-3,200	12.00 USD	$38.4K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jan 20, 2026	Sell	-3,500	12.00 USD	$42K		SEC
Enliven Therapeutics, Inc.Listing on record	Jan 12, 2026	Sell	-4,285	25.00 USD	$107.1K		SEC
Enliven Therapeutics, Inc.Listing on record	Jan 12, 2026	Sell	-1,620	25.00 USD	$40.5K		SEC
Enliven Therapeutics, Inc.Listing on record	Jan 12, 2026	Sell	-8,015	25.04 USD	$200.7K	Unusual size	SEC
Oric Pharmaceuticals, Inc.Listing on record	Jan 6, 2026	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 3, 2025	Exercise	1,447	3.75 USD	$5.4K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 3, 2025	ExerciseD (derivative)	-1,447	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 3, 2025	ExerciseD (derivative)	-18,125	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 3, 2025	Exercise	31,353	1.60 USD	$50.2K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 3, 2025	ExerciseD (derivative)	-13,228	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Jun 9, 2025	AwardD (derivative)	33,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Oric Pharmaceuticals, Inc.Listing on record	Oct 2, 2026	Exercise	3,500	1.60 USD	$5.6K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 2, 2026	ExerciseD (derivative)	-3,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 2, 2026	Sell	-3,200	12.91 USD	$41.3K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 2, 2026	Sell	-3,500	12.91 USD	$45.2K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jul 28, 2026	ExerciseD (derivative)	-3,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jul 28, 2026	Sell	-6,100	12.02 USD	$73.3K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jul 28, 2026	Sell	-7,000	12.02 USD	$84.1K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jul 28, 2026	Exercise	3,500	1.60 USD	$5.6K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jul 8, 2026	Sell	-300	12.00 USD	$3.6K		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 19, 2026	Sell	-1,230	26.18 USD	$32.2K		SEC
Enliven Therapeutics, Inc.Listing on record	Feb 17, 2026	AwardD (derivative)	19,234	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Jan 22, 2026	Sell	-512	26.46 USD	$13.5K		SEC
Enliven Therapeutics, Inc.Listing on record	Jan 22, 2026	Sell	-718	26.96 USD	$19.4K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jan 20, 2026	Sell	-3,200	12.00 USD	$38.4K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Jan 20, 2026	Sell	-3,500	12.00 USD	$42K		SEC
Enliven Therapeutics, Inc.Listing on record	Jan 12, 2026	Sell	-4,285	25.00 USD	$107.1K		SEC
Enliven Therapeutics, Inc.Listing on record	Jan 12, 2026	Sell	-1,620	25.00 USD	$40.5K		SEC
Enliven Therapeutics, Inc.Listing on record	Jan 12, 2026	Sell	-8,015	25.04 USD	$200.7K	Unusual size	SEC
Oric Pharmaceuticals, Inc.Listing on record	Jan 6, 2026	AwardD (derivative)	40,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 3, 2025	Exercise	1,447	3.75 USD	$5.4K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 3, 2025	ExerciseD (derivative)	-1,447	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 3, 2025	ExerciseD (derivative)	-18,125	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 3, 2025	Exercise	31,353	1.60 USD	$50.2K		SEC
Oric Pharmaceuticals, Inc.Listing on record	Oct 3, 2025	ExerciseD (derivative)	-13,228	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PMV Pharmaceuticals, Inc.Listing on record	Jun 9, 2025	AwardD (derivative)	33,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC